CD274 and cancer: Gene expression analysis revealed high expression of CD274 (programmed cell death ligand 1 (PD-L1)) compared to TCGA sarcoma (patient 1: 89th percentile, patient 2: 97th percentile) and POG570 pan-cancer data sets (patient 1: 83rd percentile, patient 2: 92nd percentile), indicating the presence of PD-L1-mediated immune evasion.